✨ Medicines Act Consents




NEW ZEALAND GAZETTE

No. 57


Health

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Gavilast 12 Hour Action

Active Ingredient:
Ranitidine hydrochloride 167.5mg/dose equivalent to ranitidine 150mg

Dosage Form:
Film coated tablet

New Zealand Sponsor:
Reckitt Benckiser (New Zealand) Limited

Manufacturer:
Ranbaxy Laboratories Limited, Village Ganguwala, Paonta Sahib, District Sirmour, Himachal Pradesh, India

Product:
Junior Parapaed

Active Ingredient:
Paracetamol 2.4%w/v

Dosage Form:
Oral suspension

New Zealand Sponsor:
AFT Pharmaceuticals Limited

Manufacturer:
Pinewood Laboratories Limited, Ballymacarbry, Clonmel, Co. Tipperary, Ireland

Product:
Six Plus Parapaed

Active Ingredient:
Paracetamol 5%w/v

Dosage Form:
Oral suspension

New Zealand Sponsor:
AFT Pharmaceuticals Limited

Manufacturer:
Pinewood Laboratories Limited, Ballymacarbry, Clonmel, Co. Tipperary, Ireland

Dated this 21st day of May 2003.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).

go3294


Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Arrow – Ranitidine 150

Active Ingredient:
Ranitidine hydrochloride 168mg equivalent to ranitidine 150mg

Dosage Form:
Film coated tablet

New Zealand Sponsor:
Arrow Pharmaceuticals (NZ) Limited

Manufacturer:
Arrow Pharmaceuticals Inc, Mississauga, Ontario, Canada

Product:
Arrow – Ranitidine 300

Active Ingredient:
Ranitidine hydrochloride 336mg equivalent to ranitidine 300mg

Dosage Form:
Film coated tablet

New Zealand Sponsor:
Arrow Pharmaceuticals (NZ) Limited

Manufacturer:
Arrow Pharmaceuticals Inc, Mississauga, Ontario, Canada

Product:
Nodia

Active Ingredient:
Loperamide hydrochloride 2mg

Dosage Form:
Tablet

New Zealand Sponsor:
Multichem NZ Limited

Manufacturer:
Cipla Limited, Patalganga Industrial Area, District Raigad, Maharashtra, India

Product:
Refresh Liquigel

Active Ingredient:
Carmellose sodium 10mg/mL

Dosage Form:
Eye drops, solution

New Zealand Sponsor:
Allergan New Zealand Limited

Manufacturer:
Allergan Inc., Waco, Texas, United States of America

Dated this 21st day of May 2003.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).

go3293



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2003, No 57


Gazette.govt.nz PDF NZ Gazette 2003, No 57





✨ LLM interpretation of page content

πŸ₯ Consent to Distribution of New Medicines

πŸ₯ Health & Social Welfare
21 May 2003
Medicines Act 1981, New medicines, Distribution consent, Pharmaceuticals
  • G. R. Boyd, Chief Advisor, Safety and Regulation

πŸ₯ Consent to Distribution of New Medicines

πŸ₯ Health & Social Welfare
21 May 2003
Medicines Act 1981, New medicines, Distribution consent, Pharmaceuticals
  • G. R. Boyd, Chief Advisor, Safety and Regulation